Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 197
CEO Dr. Evan Loh
Address 75 Park Plaza 4th floor, Boston, MA 02116-3934
Phone 1.617.807.6600
Website www.paratekpharma.com

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Paratek Pharmaceuticals, Inc. -12.43% 2.53%
Singular Genomics Systems, Inc. -13.16% n/a
Aclaris Therapeutics, Inc. 5.56% 289.15%
Rani Therapeutics Holdings, Inc. n/a n/a
Semler Scientific, Inc. 24.90% 143.32%

Statement Summary

as of 4:00 ET PM 10/25/2021
Total Assets (MRQ) 179.6 M
Total Liabilities (MRQ) 278.9 M
Shareholders’ Equity (MRQ) -99.3 M
Total Revenue (Annual) 57.5 M
Net Income (Annual) 9.6 M

Earnings And Estimates

as of 4:00 ET PM 10/25/2021

Current Qtr EPS Estimate -0.45
Current FY EPS Estimate -0.91
Long Term EPS Growth Estimate -35.71
Next Expected Earnings Date //

PRTK vs S&P 500

as of 10/25/2021
Relative To
S&P 500
PRTK
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 10/25/2021
Fiscal Quarter Estimate Actual Surprise
06/2021 0.36 0.20 -44.05%
03/2021 -0.56 -0.39 -30.77%
12/2020 -0.48 -0.54 +13.68%
09/2020 -0.61 -0.46 -24.59%
06/2020 -0.07 -0.53 +631.03%
03/2020 -0.80 -0.66 -17.76%
12/2019 -1.04 -0.81 -21.93%
09/2019 -1.05 -1.00 -4.31%

Financial Strength

as of 4:00 ET PM 10/25/2021
Pre-Tax Margin 16.90
Net Margin 0.00
Operating Margin 24.51
Return On Equity 0.00
Return On Assets -26.84
Inventory Turnover (TTM) 1.41
Sales Growth (MRQ) n/a

Ratios

as of 4:00 PM ET 10/26/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 0.00
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) -2.07
Quick Ratio (MRQ) 6.94
Current Ratio (MRQ) 7.32
Total Debt/Equity (MRQ) 0.00

Short Interest

as of 4:00 PM ET 10/26/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 10/25/2021
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Consensus Estimate $-0.45 $-0.27
# of Estimates 3 3
High Estimate $-0.39 $-0.07
Low Estimate $-0.55 $-0.54
Year Ago EPS $-0.46 $-0.54
Year Over Year Growth Estimate -1.84% -49.79%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-0.91 $0.21
# of Estimates 3 3
High Estimate $-0.65 $1.18
Low Estimate $-1.27 $-0.41
Year Ago EPS $-2.19 $-0.91
Year Over Year Growth Estimate -58.47% -123.25%
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.45 $-0.27 $-0.91 $0.21
# of Estimates 3 3 3 3
High Estimate $-0.39 $-0.07 $-0.65 $1.18
Low Estimate $-0.55 $-0.54 $-1.27 $-0.41
Year Ago EPS $-0.46 $-0.54 $-2.19 $-0.91
Year Over Year Growth Estimate -1.84% -49.79% -58.47% -123.25%

Insider Information Summary

as of 09/30/2021
% Insiders - 19.02%
% Remaining Total Shares - 80.98%
Current 1 Month
Net Insider Transaction 155.68 K 49.94 K
Shares Bought 251.08 K 251.08 K
Shares Sold 95.39 K 201.13 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Robinhood Lead

5 Top Stock Decliners for Wednesday: Robinhood, Twitter, Visa

Robinhood, Twitter, Visa, General Motors and Texas Instruments are five stocks that fell on Wednesday.

Watch: Jim Cramer Reacts to Advanced Micro Devices' Downgrade by Morgan Stanley

AMD Stock Rises as Analysts Boost Price Targets on Solid Earnings

Bank of America analyst Vivek Arya raises his price target to $150, and Jefferies analyst Mark Lipacis lifts his target to $145.

McDonald's Lead

5 Top Stock Gainers for Wednesday: McDonald's, Alphabet, Microsoft

McDonald's, Alphabet, Microsoft, Enphase Energy and Spotify are five top stock gainers for Wednesday.

Affirm Lead

Affirm Stock Rises on Accord to Serve American Airlines Customers

Approved American Airlines customers can use Affirm to split the total cost of flights over $50 into monthly payments.

Alphabet antitrust Lead

Alphabet Stock Up as Analysts Lift Price Targets on Earnings Beat

Analysts raise their price targets for Alphabet on the heels of the tech giant's third-quarter earnings win.

AMD Tests $30 Billion Barrier as Chipmaker Rides Torrid Gains to Challenge Intel

AMD Stock: Here's Where to Buy the Dip After the Earnings Report

AMD stock is struggling for upside traction after another solid earnings report. Here's where investors should be looking to buy the dip.

Twitter Lead

Twitter Stock Drops; Analysts Cut Price Targets as User Growth Lags

Wall Street cut its price targets on Twitter after the microblogging site's third-quarter earnings report.

Wake Up Wall Street: Concerns About The U.S's Possible Withdrawal From Paris Climate Agreement

Stocks Edge Lower; Microsoft Earnings Leap, Billionaires' Tax Plan - 5 Things You Must Know

Stocks edge lower after record highs; Microsoft tops earnings forecast on cloud strength; Pfizer gets nod for children's vaccine; Democrats unveil billionaires tax' Robinhood shares tumble after softer third quarter revenues.

Move Over, REITs; BDCs Aren't Afraid of Increasing Interest Rates

Bank of Canada Rate Hike Signal Spikes Treasury Yields, Pressures Fed

Short-term U.S. Treasury yields leapt higher Wednesday after the Bank of Canada shut down its QE program and signaled for an early 2022 rate hike just days ahead of a crucial Fed policy meeting.

Wall Street Lead

Dow Falls 100 Points as Markets Back Off From Record Highs

Stocks are mixed Wednesday as investors react to a fresh line of corporate-earnings reports.